MedPath

The Effect of Continuous Care Model on Self-Efficacy and Adherence to Treatment in Patients Undergoing Coronary Bypass Graft

Not Applicable
Recruiting
Conditions
Coronary artery bypass graft.
Atherosclerosis of coronary artery bypass graft(s), unspecified, with angina pectoris
I25.70
Registration Number
IRCT20230924059499N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Age 18 to 65 years
Patients undergoing coronary bypass graft surgery for the first time
Being alert
Not being in dire and emergency situations
24 hours have passed since the patient was admitted
No debilitating disease
Not preventing speech, hearing and vision and able to establish communication and cooperationIt
Is the absence of physical and mental diseases that affect the quality of life, such as dialysis or other mental problems, such as complications and problems that require medication or a special diet
Access to a smartphone with the ability to install messenge

Exclusion Criteria

Do not attend two (or more) meetings out of the total number of meetings
People who have participated in another educational program during the research
People who enter the acute phase of the disease and need to be re-hospitalized
Transfer from the desired research unit to another unit
Withdrawal from participating in the study
Failure to answer all questions in the questionnaire

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Esteka's general self-efficacy. Timepoint: Measuring self-efficacy at the beginning of the study and 56 days after the start of the intervention. Method of measurement: Estaka General Self-Efficacy Questionnaire.;Adherence to treatment. Timepoint: Measurement of adherence to treatment at the beginning of the study and 56 days after the start of the intervention. Method of measurement: Modanlo adherence to treatment Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath